Notch receptors are involved in regulating the balance between cell differentiation and stem cell proliferation during the development of numerous tissues (Artavanis-Tsakonas, S
Results
In vertebrates, there are four Notch genes (Kasahara et al., 1997) and it was recently shown that Notch signaling can alter cell fate decisions in pancreatic epithelium (Apelqvist et al., 1999) . Moreover, mice lacking HES 1, a down-stream target of Notch 1, display severe pancreatic hypoplasia caused by depletion of pancreatic epithelial precursors (Jensen et al., 2000) .
To date, it is not known in which of the different pancreatic cell types the four Notch genes or their ligands are expressed. It is also unclear whether Notch expression is excluded from cells expressing differentiation markers, which would support a role of Notch for precursor cells. We have therefore performed a straightforward expression analysis of the four Notch genes, along with some of their ligands (Delta-like 1, Serrate 1 and 2), during pancreatic organogenesis. We also analyzed down-stream bHLH targets such as HES 1, which is induced by Notch 1 (Kageyama and Nakanishi, 1997) , and NeuroD/BETA-2, shown to be down-regulated by Notch 1 during neurogenesis (Chitnis and Kintner, 1996) . Through a combination of Notch in situ hybridization and antibody staining, we obtained information about coexpression of Notch with differentiation markers such as Glucagon.
At e9.5, an early stage of pancreatic development, the endocrine marker Glucagon is expressed in a few scattered cells within the epithelium (Fig. 1A) . All Glucagon-expressing cells co-express NeuroD/BETA-2 (Fig. 1B) , a bHLH transcription factor required for development of endocrine cells (Lee, 1997; Naya et al., 1997) . A separate set of cells express Notch 1, and these cells do not co-express Glucagon (Fig. 1A) . NeuroD can activate the insulin promotor (Naya et al., 1995) and we note that about a quarter of the Glucagon expressing cells strongly co-express Insulin (Fig. 1C) . In the e10.5 pancreas, Notch 1 expression is striking in that it is expressed more uniformly, in both the dorsal and ventral pancreatic buds (Fig. 1D,E ), but not in the Glucagon expressing cells located at the periphery of the epithelium (Fig. 1D,G,H) , the adjacent gut tube, or pancreatic mesenchyme. The punctate Notch 1 expression in the mesenchyme represents endothelial cells. HES 1 is clearly expressed in some, but not all, cells of the pancreatic epithelium ( Fig.  1F ), indicating that a subset of the Notch1 positive cells are active in Notch 1 signaling. Cells expressing high levels of HES 1 (arrow) do not co-express Glucagon (arrowhead; Fig.  1F , inset).
Notch 3, which antagonizes Notch 1 signaling , is strongly expressed in the surrounding pancreatic mesenchyme and not in the epithelium (compare Fig. 1D with Fig. 1G ). Notch 4 (Uyttendaele et al., 1996) is expressed in some cells of the pancreatic mesenchyme, apparently endothelial cells (Fig. 1H ). Notch 4 expressing cells directly adjacent to Glucagon expressing cells are likely to be endothelial cells, which are frequently observed close to endocrine cells, although it is dif®cult to exclude the possibility that these cells belong to the pancreatic epithelium.
In the e11.5 embryo, when the pancreatic bud branches and gives rise to ducts, Notch 2 becomes strongly expressed in what appear to be the ductal cells (Fig. 1I, arrow) . Similar to Notch 1, Notch 2 expression is excluded from Glucagon expressing cells and pancreatic mesenchyme (although it is expressed in stomach mesenchyme). At e11.5, Notch 1 and Notch 2 expression overlap, but as development proceeds, the expression patterns diverge ( Fig. 2A,B) . By day 15.5, Notch 2 expression is absolutely restricted to ductal cells (Fig. 2B) , the cells believed to be the source of endocrine and exocrine stem cells (Teitelman et al., 1993) . In the e14.5 pancreas, Notch 1 is more broadly expressed in the pancreatic epithelium including the acini (and in some endothelial cells) (Fig. 2A) . In contrast to Notch 2, its epithelial expression starts to decline after embryonic day 14.5.
Interestingly, NeuroD is expressed in cells adjacent to, but not within, the duct cell population (data not shown). Similarly, endo-and exocrine cells of the e15.5 pancreas are closely associated with the ducts, but do not express Notch 2 (Fig. 2C±E ). This suggests that differentiated cells develop from Notch 2-expressing cells. The scattered expression of Dll 1, a Notch ligand (Bettenhausen, 1995) , within the duct epithelium (Fig. 2F ) suggests cellular differences within the Notch 2 expressing duct cell population. Duct cells which Fig. 1 . An activated Notch 1 pathway and distinct expression patterns of the Notch genes in the embryonic pancreas. In situ hybridizations (blue or violet color) and Glucagon (Glu) immuno-stainings (brown or black color) were sequentially performed on transverse sections of mouse embryos from different days of gestation (9.5, 10.5 and 11.5). In dorsal pancreatic e9.5 buds, expression of Notch 1 and Glucagon do not overlap (arrows A: scale bar, 2.5 mm). All Glucagon expressing cells co-express NeuroD (B), some of them Insulin (C). Dorsal (dp) and ventral (vp) e10.5 pancreatic buds express Notch 1 (D,E: scale bar, 20 mm) in their epithelium (e) but not mesenchyme (m). HES1 expression (F) is similar to the Notch 1 pattern, and it does not overlap with Glucagon (F, inset). Notch 3 is expressed in pancreatic mesenchyme (m) but not in the pancreatic epithelium (e) (G). Notch 4 is expressed in what appear to be endothelial cells (arrows) (H). Pancreatic Notch 2 expression is strong in cells of the ducts (arrow) at around e11.5 (I). dp, dorsal pancreas; vp, ventral pancreas; st, stomach. stain strongly for Dll 1 do not co-express Glucagon (Fig. 2F,  inset) and might represent pro-endocrine cells.
After their initial expression in early pancreatic mesenchyme, Notch 3 and 4 are expressed in the endothelial cells of the e15.5 pancreas (Fig. 3A±D) . The endothelial cells are characterized by their¯at shape and the fact that they face a lumen in which blood cells can be observed (while looking at the adjacent sections). The Notch ligands Serrate 1 (Mitsiadis et al., 1997) and Serrate 2 (Jiang et al., 1998) are also expressed in endothelial cells (Fig. 3E,F) . Recently, it was shown that ectopic expression of Notch 3 in the pancreatic epithelium impairs pancreatic epithelial proliferation and morphogenesis (Apelqvist et al., 1999) . The ®nding that Notch 3 is strongly expressed in pancreatic mesenchyme, but not in epithelium (Figs. 1G and 3A,B) , argues against Notch 3 ± mediated inhibition of Notch 1 as the major form of Notch 1 regulation in the pancreatic epithelium.
Materials and methods
In situ hybridizations were performed on transverse sections of ICR mouse embryos. Hybridizations of DIGlabeled RNA at 708C were followed by an AP-conjugated sheep anti-DIG antibody catalyzing an NBT/BCIP color reaction (Roche Molecular Biochemicals). The probes (except for the mouse Insulin-2 probe) were gifts from Jaqueline E. Lee (NeuroD), Ryoichiro Kageyama (HES 1), Thimios A. Mitsiadis and Urban Lendahl (Notch 1, 2 and 3), Jan Kitajewski (Notch 4/int-3), Achim Gossler (Dll 1), Andrew McMahon (Serrate 1), and Thomas Gridley (Serrate 2). After hybridizations, most of the sections were immunostained with one of the following antibodies: guinea pig anti-Glucagon, guinea pig anti-rat C-peptide (Linco Research), rabbit anti-human a-Amylase (Sigma). Biotinconjugated secondary antibodies were used along with ABC and DAB kits (Vector Laboratories). Fig. 2 . Restriction of Notch 2 expression to embryonic ducts. In situ hybridizations (violet or blue color) and immuno-stainings (brown color) were sequentially performed on sections of e14.5 (A) and e15.5 (B±F) mouse dorsal pancreata (dp) and stomachs (st). While Notch 1 is broadly expressed in the dorsal pancreas (A: scale bar, 20 mm), Notch 2 is exclusively expressed in pancreatic ducts (B: scale bar, 20 mm). The expression of Notch 2 does not overlap with endocrine and exocrine differentiation markers such as Glucagon (C: scale bar, 5 mm), Insulin (D), and Amylase (E). The Notch ligand Delta-like 1 (Dll 1) is expressed in the pancreatic epithelium (F). Duct cells expressing high levels of Dll 1 do not co-express Glucagon (F, inset). Fig. 3 . Expression of Notch 3 and 4 and Serrate 1 and 2 in pancreatic endothelial cells. In situ hybridizations (blue color) and immuno-stainings (brown±black color) were sequentially performed on sections of e15.5 mouse pancreata. Notch 3 and 4 are expressed in endothelial cells (A: scale bar, 10 mm; B: scale bar, 5 mm; C,D). The Notch ligands Serrate 1 (E) and Serrate 2 (F) are also expressed in pancreatic endothelial cells. dp, dorsal pancreas; sp, spleen. Blood vessels are indicated (v, arrows) .
